The effect of paroxetine on 5-HT2A receptors in depression: An [18F]setoperone PET imaging study

American Journal of Psychiatry

Volumn 158, Issue 1, 2001, Pages 78-85

  Meyer, J H ^a   Kapur, S ^a   Eisfeld, B ^a   Brown, G M ^a   Houle, S ^a   DaSilva, J ^a   Wilson, A A ^a   Rafi Tari, S ^a   Mayberg, H S ^a   Kennedy, S H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN 2A RECEPTOR; SETOPERONE;

ADULT; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; HUMAN; MALE; MOOD; NERVE CELL GROWTH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ADOLESCENT; ADULT; AGE FACTORS; CEREBRAL CORTEX; DEPRESSIVE DISORDER; DOWN-REGULATION; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; PAROXETINE; PYRIMIDINONES; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0035167167     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.1.78     Document Type: Article

References (56)

1. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei
2. A molecular and cellular theory of depression
3. 2A Receptor-mediated regulation of brain derived neurotrophic factor mRNA in the hippocampus and the neocortex
4. 2c receptors expressed in the human neuroblastoma cell line SH-SY5Y: Comparative stimulation by hallucinogenic drugs
5. An hallucinogenic amphetamine analog (DOM) in man
6. 2,5-Dimethoxy-4-methyl-amphetamine (STP): A new hallucinogenic drug
7. DOM (STP), A new hallucinogenic drug, and DOET: Effects in normal subjects
8. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding
9. 2 sites
10. 2 receptors in rat brain: An autoradiographic study
11. 2 receptors
12. Receptor alterations associated with serotonergic agents: An autoradiographic analysis
13. 2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors
14. Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex
15. B receptors in midbrain raphe nuclei and forebrain of rats
16. Both systemic and local administration of benzodiazepine agonists inhibit the in vivo release of 5-HT from ventral hippocampus
17. 2A receptor
18. 2A receptors unchanged by antidepressant treatment
19. 18F]setoperone: A new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo
20. 3H]ketanserin binding in the human brain postmortem: Effect of suicide
21. 3H]mesulergine binding in human brain postmortem
22. 2 dopamine receptors in the human brain
23. 2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent ziprasidone
24. 2-receptors in human brain
25. 18F-setoperone studied in humans using positron emission tomography
26. 18F]setoperone PET imaging study
27. 2 receptors by DOM treatment
28. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2
29. A rating scale for depression
30. An improved method for the measurement of paroxetine in human/serum plasma by HPLC with fluorescence detection
31. 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors
32. 18F-labeled setoperone
33. 18F]setoperone PET imaging
34. Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis
35. Spatial registration and normalisation of images
36. Statistical parametric maps in functional imaging: A general linear approach
37. Assessing the significance of focal activations using their spatial extent
38. Assessment of spatial normalization of PET ligand images using ligand-specific templates
39. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures
40. 18F]setoperone in neuroleptic-naive patients and normal subjects
41. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites
42. 3H]ketanserin binding in the human brain postmortem: Effect of suicide
43. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders
44. 18F]-setoperone PET
45. 2 receptors, roles and regulation
46. Interactions between effectors linked to serotonin receptors
47. 2c): Where structure meets function
48. Age-related alteration of PKC, a key enzyme in memory processes: Physiological and pathological examples
49. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study
50. Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat
51. 2 receptor binding in patients with major depression following desipramine treatment: A positron emission tomography study with fluorine-18-labeled setoperone
52. 3H]paroxetine binding, a marker of serotonin uptake sites
53. The primate serotonergic system: A review of human and animal studies and a report on Macaca fascicularis
54. 2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites